Article ; Online: Managing Survivorship after Hematopoietic Cell Transplantation.
Current hematologic malignancy reports
2023 Volume 18, Issue 3, Page(s) 75–82
Abstract: Purpose of review: With improvement in survival after hematopoietic cell transplantation (HCT), it has become important to focus on the late complications experienced by the survivors that may lead to late mortality and morbidity to be able to provide ... ...
| Abstract | Purpose of review: With improvement in survival after hematopoietic cell transplantation (HCT), it has become important to focus on the late complications experienced by the survivors that may lead to late mortality and morbidity to be able to provide patient-centered care across the transplant continuum. The goals of this article are to describe the status of literature on late complications in HCT survivors; offer a brief overview of the status of the screening, prevention, and management of these complications; and identify opportunities for future practice and research. Recent findings: This is an exciting time for the field with increasing awareness about survivorship issues. Studies are moving beyond description to examining pathogenesis of these late complications and identifying biomarkers. The eventual goal is to promote changes in our transplant techniques to decrease the incidence of these complications as well as help develop interventions targeting these late effects. There is also an emphasis on improving health care delivery models to provide optimal post-HCT management for medical and psychosocial complications through close coordination between multiple stakeholders and leveraging technology to help address the barriers in delivery of care to fulfill the unmet needs in this area. The increasing population of HCT survivors with their burden of late effects underscores the need for concerted efforts to improve long-term medical and psychosocial outcomes for this group. |
|---|---|
| MeSH term(s) | Humans ; Survivorship ; Hematopoietic Stem Cell Transplantation/adverse effects ; Hematopoietic Stem Cell Transplantation/methods ; Survivors ; Delivery of Health Care ; Biomarkers ; Disease Progression |
| Chemical Substances | Biomarkers |
| Language | English |
| Publishing date | 2023-03-30 |
| Publishing country | United States |
| Document type | Journal Article ; Review |
| ZDB-ID | 2229765-0 |
| ISSN | 1558-822X ; 1558-8211 |
| ISSN (online) | 1558-822X |
| ISSN | 1558-8211 |
| DOI | 10.1007/s11899-023-00694-8 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6332: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.